Manijeh Goldberg

Biography

Manijeh is the Founder and CEO of Privo. She has over 20 years of experience in the biomedical industry, in large companies and five startups (one was acquired for $275M). She holds a PhD in Biomedical Engineering, an MS in Biomedical Enterprise from Harvard Medical School, an MBA from MIT, and an MS in Computer Science and Mathematics. 

Research Interest

Privo Technologies, Inc. is a privately funded company that spun out of the world-renowned Langer Laboratory at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, USA. Privo is developing a novel, nanotechnology-based drug delivery platform capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa. This approach eliminates needles, avoids stomach acids, can significantly reduce toxic side effects of drugs, and allows for higher dosing where the drugs can be most effective – all of which improve patient outcomes and compliance.